Sample | Title | Value | Rank |
GSM967852 | U87-EV human glioblastoma xenograft - Control 1 | 4.64301 | 73 |
GSM967853 | U87-EV human glioblastoma xenograft - Control 2 | 4.36851 | 70 |
GSM967854 | U87-EV human glioblastoma xenograft - Control 3 | 4.45778 | 71 |
GSM967855 | U87-EV human glioblastoma xenograft - Control 4 | 4.28182 | 69 |
GSM967856 | U87-EV human glioblastoma xenograft - Control 5 | 4.41664 | 71 |
GSM967862 | U87-EV human glioblastoma xenograft - Bevacizumab treated 1 | 4.8019 | 75 |
GSM967863 | U87-EV human glioblastoma xenograft - Bevacizumab treated 2 | 4.99825 | 76 |
GSM967864 | U87-EV human glioblastoma xenograft - Bevacizumab treated 3 | 4.63227 | 73 |
GSM967865 | U87-EV human glioblastoma xenograft - Bevacizumab treated 4 | 4.36386 | 70 |
GSM967857 | U87-EV human glioblastoma xenograft - dibenzazepine treated 1 | 4.33604 | 70 |
GSM967858 | U87-EV human glioblastoma xenograft - dibenzazepine treated 2 | 4.47922 | 71 |
GSM967859 | U87-EV human glioblastoma xenograft - dibenzazepine treated 3 | 4.39495 | 70 |
GSM967860 | U87-EV human glioblastoma xenograft - dibenzazepine treated 4 | 4.57059 | 72 |
GSM967861 | U87-EV human glioblastoma xenograft - dibenzazepine treated 5 | 4.58423 | 72 |